Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer

Por Z. A.-G. Radzhabova, M. A. Kotov, Z. S. Bekyasheva, M. A. Radzhabova, E. V. Levchenko
Publicado em 2020-02-01

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

Por Robison, Nathan J, Campigotto, Federico, Chi, Susan N, Manley, Peter E, Turner, Christopher D, Zimmerman, Mary Ann, Chordas, Christine A, Werger, Annette M, Allen, Jeffrey C, Goldman, Stewart, Rubin, Joshua B, Isakoff, Michael S, Pan, Wilbur J, Khatib, Ziad A, Comito, Melanie A, Bendel, Anne E, Pietrantonio, Jay B, Kondrat, Laura, Hubbs, Shannon M, Neuberg, Donna S, Kieran, Mark W
Publicado no Pediatr Blood Cancer (2014)

A phase II trial of abiraterone combined with dutasteride for men with metastatic castration-resistant prostate cancer

Por McKay, Rana R., Werner, Lillian, Mostaghel, Elahe A., Lis, Rosina, Voznesensky, Olga, Zhang, Zhenwei, Marck, Brett T., Matsumoto, Alvin M., Domachevsky, Liran, Zukotynski, Katherine A., Bhasin, Manoj, Bubley, Glenn J., Montgomery, Bruce, Kantoff, Philip W., Balk, Steven P., Taplin, Mary-Ellen
Publicado no Clin Cancer Res (2016)

Alteration of Daily and Circadian Rhythms following Dopamine Depletion in MPTP Treated Non-Human Primates

Por Fifel, Karim, Vezoli, Julien, Dzahini, Kwamivi, Claustrat, Bruno, Leviel, Vincent, Kennedy, Henry, Procyk, Emmanuel, Dkhissi-Benyahya, Ouria, Gronfier, Claude, Cooper, Howard M.
Publicado em 2014

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Por Kwak, Eunice L., Bang, Yung-Jue, Camidge, D. Ross, Shaw, Alice T., Solomon, Benjamin, Maki, Robert G., Ou, Sai-Hong I., Dezube, Bruce J., Jänne, Pasi A., Costa, Daniel B., Varella-Garcia, Marileila, Kim, Woo-Ho, Lynch, Thomas J., Fidias, Panos, Stubbs, Hannah, Engelman, Jeffrey A., Sequist, Lecia V., Tan, WeiWei, Gandhi, Leena, Mino-Kenudson, Mari, Wei, Greg C., Shreeve, S. Martin, Ratain, Mark J., Settleman, Jeffrey, Christensen, James G., Haber, Daniel A., Wilner, Keith, Salgia, Ravi, Shapiro, Geoffrey I., Clark, Jeffrey W., Iafrate, A. John
Publicado em 2010

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non...

Por Dy, Grace K., Hillman, Shauna L., Rowland, Kendrith M., Molina, Julian R., Steen, Preston D., Wender, Donald B., Nair, Suresh, Mandrekar, Sumithra, Schild, Steven E., Adjei, Alex A.
Publicado no Cancer (2010)

A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent...

Por Zhao, Yujie, Foster, Nathan R., Meyers, Jeffrey P., Thomas, Sachdev P., Northfelt, Donald W., Rowland, Kendrith M., Mattar, Bassam I., Johnson, David B., Molina, Julian R., Mandrekar, Sumithra J., Schild, Steven E., Bearden, James D., Aubry, Marie-Christine, Adjei, Alex A.
Publicado no J Thorac Oncol (2015)

LONG-TERMS RESULTS OF A TRIAL OF CONCURRENT CHEMOTHERAPY AND ESCALATING DOSES OF RADIATION...

Por Schild, Steven E., Hillman, Shauna L., Tan, Angelina D., Ross, Helen J., McGinnis, William L., Garces, Yolanda A., Graham, David L., Adjei, Alex A., Jett, James R.
Publicado no J Thorac Oncol (2017)

Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials

Por Pariser, David M., Hebert, Adelaide A., Drew, Janice, Quiring, John, Gopalan, Ramanan, Glaser, Dee Anna
Publicado no Am J Clin Dermatol (2018)

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies

Por Busse, Paula J., Farkas, Henriette, Banerji, Aleena, Lumry, William R., Longhurst, Hilary J., Sexton, Daniel J., Riedl, Marc A.
Publicado no BioDrugs (2018)

Induction therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial...

Por Boland, Patrick M, Meyer, Joshua E, Berger, Adam C, Cohen, Steven J, Neuman, Tzahi, Cooper, Harry S, Olszanski, Anthony J, Davey, Monica, Cheng, Jonathan D, Lebenthal, Abraham, Burtness, Barbara A, Scott, Walter J, Astsaturov, Igor A
Publicado no Am J Clin Oncol (2017)

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study

Por Van Cutsem, E, Yoshino, T, Lenz, H J, Lonardi, S, Falcone, A, Limón, M L, Saunders, M, Sobrero, A, Park, Y S, Ferreiro, R, Hong, Y S, Tomasek, J, Taniguchi, H, Ciardiello, F, Stoehr, J, Oum’Hamed, Z, Vlassak, S, Studeny, M, Argiles, G
Publicado no Ann Oncol (2018)

First Report of NRG Oncology RTOG 0622: A Phase II Trial of Samarium-153 Followed by Salvage...

Por Valicenti, Richard K, Pugh, Stephanie L, Trabulsi, Edouard J, Sartor, Oliver, Ko, Eric C, Girvigian, Michael R, Rosenthal, Seth A, Shaves, Mark E, Hoffman-Censits, Jeannie H, Schallenkamp, John, Sandler, Howard M
Publicado no Int J Radiat Oncol Biol Phys (2017)

Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

Por Dassen, Anneriet E, Bernards, Nienke, Lemmens, Valery E P P, van de Wouw, Yes A J, Bosscha, Koop, Creemers, Geert-Jan, Pruijt, Hans J F M
Publicado no World J Gastrointest Surg (2016)

Acceptability and potential effectiveness of a foot drop stimulator in children and adolescents with cerebral palsy

Por PROSSER, LAURA A, CURATALO, LINDSEY A, ALTER, KATHARINE E, DAMIANO, DIANE L
Publicado em 2012

Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study

Por Willmann, Stefan, Thelen, Kirstin, Kubitza, Dagmar, Lensing, Anthonie W. A., Frede, Matthias, Coboeken, Katrin, Stampfuss, Jan, Burghaus, Rolf, Mück, Wolfgang, Lippert, Jörg
Publicado no Thromb J (2018)

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial

Por Pili, Roberto, Liu, Glenn, Chintala, Sreenivasulu, Verheul, Hendrick, Rehman, Shabnam, Attwood, Kristopher, Lodge, Martin A, Wahl, Richard, Martin, James I, Miles, Kiersten Marie, Paesante, Silvia, Adelaiye, Remi, Godoy, Alejandro, King, Serina, Zwiebel, James, Carducci, Michael A
Publicado no Br J Cancer (2017)

Efficacy and Safety of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma: A Prospective Multi-center Phase II Study of by the Puget Sound...

Por Gopal, Ajay K., Press, Oliver W., Shustov, Andrei R., Petersdorf, Stephen H., Gooley, Ted A., Daniels, Jasmine T., Garrison, Mitchell A., Gjerset, George F., Lonergan, Matthew, Murphy, Anne E., Smith, Julie C., Pagel, John M.
Publicado em 2010

Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

Por Barnes, Jeffrey A., Jacobsen, Eric, Feng, Yang, Freedman, Arnold, Hochberg, Ephraim P., LaCasce, Ann S., Armand, Philippe, Joyce, Robin, Sohani, Aliyah R., Rodig, Scott J., Neuberg, Donna, Fisher, David C., Abramson, Jeremy S.
Publicado em 2013

Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer

Por Conroy, T, Hebbar, M, Bennouna, J, Ducreux, M, Ychou, M, Llédo, G, Adenis, A, Faroux, R, Rebischung, C, Kockler, L, Douillard, J Y
Publicado em 2010